272 related articles for article (PubMed ID: 24228821)
1. Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong.
Chui KS; Wu HL; You JH
Scand J Infect Dis; 2014 Jan; 46(1):27-33. PubMed ID: 24228821
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of varicella vaccine as post exposure prophylaxis in Chilean children].
Pinochet C; Cerda J; Hirsch T; Mieres J; Inostroza C; Abarca K
Rev Chilena Infectol; 2012 Dec; 29(6):635-40. PubMed ID: 23412032
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
You JH; Ming WK; Chan PK
Hum Vaccin Immunother; 2015; 11(3):564-71. PubMed ID: 25714506
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of varicella vaccines as postexposure prophylaxis.
Brotons M; Campins M; Méndez L; Juste C; Rodrigo JA; Martínez X; Hermosilla E; Pinós L; Vaqué J
Pediatr Infect Dis J; 2010 Jan; 29(1):10-3. PubMed ID: 19841607
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study.
Wu Q; Liu J; Wang Y; Zhou Q; Wang X; Xuan Z; Zhang L; Gao Y; Chen B; Hu Y
Clin Microbiol Infect; 2019 Jul; 25(7):872-877. PubMed ID: 30472425
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of varicella vaccine as post-exposure prophylaxis during a varicella outbreak in Shanghai, China.
Wu QS; Liu JY; Wang X; Chen YF; Zhou Q; Wu AQ; Wang L
Int J Infect Dis; 2018 Jan; 66():51-55. PubMed ID: 29107654
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
Smith KJ; Roberts MS
Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
Ahern S; Browne J; Murphy A; Teljeur C; Ryan M
Vaccine; 2024 May; 42(14):3321-3332. PubMed ID: 38609807
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
Macartney K; Heywood A; McIntyre P
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001833. PubMed ID: 24954057
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of the universal varicella vaccination program in the United States.
Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of rabies post exposure prophylaxis in Iran.
Hatam N; Esmaelzade F; Mirahmadizadeh A; Keshavarz K; Rajabi A; Afsar Kazerooni P; Ataollahi M
J Res Health Sci; 2014; 14(2):122-7. PubMed ID: 24728746
[TBL] [Abstract][Full Text] [Related]
12. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia.
Paternina-Caicedo A; De la Hoz-Restrepo F; Gamboa-Garay O; Castañeda-Orjuela C; Velandia-González M; Alvis-Guzmán N
Vaccine; 2013 Jan; 31(2):402-9. PubMed ID: 23174195
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of varicella vaccination programs: an update of the literature.
Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
[TBL] [Abstract][Full Text] [Related]
14. Varicella vaccination in Italy : an economic evaluation of different scenarios.
Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
Macartney K; McIntyre P
Cochrane Database Syst Rev; 2008 Jul; (3):CD001833. PubMed ID: 18646079
[TBL] [Abstract][Full Text] [Related]
16. Varicella vaccination in England and Wales: cost-utility analysis.
Brisson M; Edmunds WJ
Arch Dis Child; 2003 Oct; 88(10):862-9. PubMed ID: 14500303
[TBL] [Abstract][Full Text] [Related]
17. The economic value of childhood varicella vaccination in France and Germany.
Coudeville L; Brunot A; Szucs TD; Dervaux B
Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
[TBL] [Abstract][Full Text] [Related]
19. Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
Wong C; Jiang M; You JH
PLoS One; 2016; 11(12):e0169030. PubMed ID: 28006012
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.
Talbird SE; Brogan AJ; Winiarski AP
Am J Prev Med; 2009 Nov; 37(5):381-8. PubMed ID: 19840692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
